The development and implementation of the approaches of personalized medicine for disease prevention are still at infancy, although preventive activities in healthcare represent a key pillar to guarantee health system sustainability. There is an increasing interest in finding informative markers that indicate the disease risk before the manifestation of the disease (primary prevention) or for early disease detection (secondary prevention). Recently, the systematic collection and study of clinical phenotypes and biomarkers consented to the advance of Rehabilomics in tertiary prevention. It consents to identify relevant molecular and physiological factors that can be linked to plasticity, treatment response, and natural recovery. Implementation of these approaches would open avenues to identify people at high risk and enable new preventive lifestyle interventions or early treatments targeted to their individual genomic profile, personalizing prevention and rehabilitation. The integration of personalized medicine into prevention may benefit citizens, patients, healthcare professionals, healthcare authorities, and industry, and ultimately will seek to contribute to better health and quality of life for Europe’s citizens.

Pastorino, R., Loreti, C., Giovannini, S., Ricciardi, W., Padua, L., Boccia, S., Challenges of Prevention for a Sustainable Personalized Medicine, <<JOURNAL OF PERSONALIZED MEDICINE>>, 4; 2021 (11): 1-9. [doi:10.3390/jpm11040311] [http://hdl.handle.net/10807/178771]

Challenges of Prevention for a Sustainable Personalized Medicine

Pastorino;Roberta; Loreti
;
Claudia; Giovannini;Silvia; Ricciardi;Walter; Padua;Luca; Boccia
2021

Abstract

The development and implementation of the approaches of personalized medicine for disease prevention are still at infancy, although preventive activities in healthcare represent a key pillar to guarantee health system sustainability. There is an increasing interest in finding informative markers that indicate the disease risk before the manifestation of the disease (primary prevention) or for early disease detection (secondary prevention). Recently, the systematic collection and study of clinical phenotypes and biomarkers consented to the advance of Rehabilomics in tertiary prevention. It consents to identify relevant molecular and physiological factors that can be linked to plasticity, treatment response, and natural recovery. Implementation of these approaches would open avenues to identify people at high risk and enable new preventive lifestyle interventions or early treatments targeted to their individual genomic profile, personalizing prevention and rehabilitation. The integration of personalized medicine into prevention may benefit citizens, patients, healthcare professionals, healthcare authorities, and industry, and ultimately will seek to contribute to better health and quality of life for Europe’s citizens.
Inglese
Pastorino, R., Loreti, C., Giovannini, S., Ricciardi, W., Padua, L., Boccia, S., Challenges of Prevention for a Sustainable Personalized Medicine, <<JOURNAL OF PERSONALIZED MEDICINE>>, 4; 2021 (11): 1-9. [doi:10.3390/jpm11040311] [http://hdl.handle.net/10807/178771]
File in questo prodotto:
File Dimensione Formato  
2021 - JPM - Challenges of Prevention for a Sustainable Personalized Medicine.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 711.3 kB
Formato Adobe PDF
711.3 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/178771
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact